Advanced filters
News
People with SMA Type 1 and 2 may be able to take the oral drug if Spinraza, the first treatment for…
News
On 6th May, SMA UK, TreatSMA and MDUK, sent this joint letter to the NICE Programme Director –…
News
We have not taken this decision lightly as we look to protect the research we are invested in as…
News
You can read the statement in full here.
The statement sets out considerations for patients (and/…
News
AveXis started to roll out this programme in January 2020 for children age under 2 years who have…
News
While muscle-wasting conditions affect around 70,000 people in the UK, the conditions MDUK supports…
News
After an international study, The IMP has released updated guidance on the medicines that should be…
News
The study showed improvement in muscle function in people with SMA type 2 and 3 when treated with…
News
The study will involve an interview with a researcher which would take around 1 to 1.5 hours and…
News
The teams have identified the molecular target for the utrophin modulator drug, ezutromid. Utrophin…